Animal trials with tissue heart valve promising
This article was originally published in Clinica
Executive Summary
Initial animal trials with tissue engineered (TE) heart valve leaflets have demonstrated the feasibility of using the technology to create valve replacement products. Advanced Tissue Sciences, which is jointly developing the BioXenoGraft with St Jude Medical, presented data on progress with the tissue engineered valve at the American Heart Association meeting in Anaheim last month.